Anastasios G P Konstas
Overview
Explore the profile of Anastasios G P Konstas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yucel Gencoglu A, Irkec M, Kocabeyoglu S, Dikmen Z, Karakaya J, Konstas A
Eur J Ophthalmol
. 2021 Dec;
32(5):2893-2898.
PMID: 34878321
Purpose: To compare plasma levels of sirtuin 1 (SIRT1) and adiponectin (APN) in patients with primary open-angle glaucoma (POAG), exfoliative glaucoma (XFG), and healthy control subjects. Methods: This prospective case-control...
2.
Mansour A, Konstas A, Mansour H, Charbaji A, El Jawhari K
Middle East Afr J Ophthalmol
. 2021 Jul;
28(1):36-50.
PMID: 34321821
The purpose of the study is to evaluate the risk factors associated with exfoliation in a case-cohort setting and literature review. This single-center, prospective, case-cohort study was carried out from...
3.
Li Z, Wang Z, Lee M, Zenkel M, Peh E, Ozaki M, et al.
JAMA
. 2021 Feb;
325(8):753-764.
PMID: 33620406
Importance: Exfoliation syndrome is a systemic disorder characterized by progressive accumulation of abnormal fibrillar protein aggregates manifesting clinically in the anterior chamber of the eye. This disorder is the most...
4.
Quaranta L, Bruttini C, Micheletti E, Konstas A, Michelessi M, Oddone F, et al.
Surv Ophthalmol
. 2021 Feb;
66(5):693-713.
PMID: 33582161
Glaucoma is an optic neuropathy characterized by well-defined optic disc morphological changes (i.e., cup enlargement, neuroretinal border thinning, and notching, papillary vessel modifications) consequent to retinal ganglion cell loss, axonal...
5.
Bezci Aygun F, Kocabeyoglu S, Irkec M, Dikmen Z, Umaroglu M, Konstas A
J Glaucoma
. 2020 Apr;
29(7):593-597.
PMID: 32287143
Purpose: To evaluate apelin and ADMA levels in serum samples from patients with XFS or XFG compared with healthy control subjects. Methods: Serum ADMA and apelin concentrations were evaluated from...
6.
Arranz-Marquez E, Katsanos A, Kozobolis V, Konstas A, Teus M
Adv Ther
. 2019 Mar;
36(4):786-797.
PMID: 30859502
During the last 2 decades, modifying the shape of the cornea by means of laser photoablation has emerged as a successful and popular treatment option for refractive errors. Corneal surface...
7.
Boboridis K, Konstas A
Expert Opin Pharmacother
. 2018 May;
19(9):1027-1039.
PMID: 29847195
Ocular surface disease (OSD) is a highly prevalent symptomatic condition caused by dry eye disease (DED), intrinsic, environmental, or iatrogenic causes. It affects patient's visual function and quality of life....
8.
Katsanos A, Gorgoli K, Mikropoulos D, Arranz-Marquez E, Athanasopoulos G, Teus M, et al.
Expert Opin Biol Ther
. 2018 May;
18(6):719-724.
PMID: 29781319
Ranibizumab was the first anti-vascular endothelial growth factor (VEGF) agent approved for the treatment of neovascular age-related macular degeneration. The use of ranibizumab and other anti-VEGF medications in recent years...
9.
Konstas A, Ringvold A
J Glaucoma
. 2018 Feb;
27 Suppl 1:S4-S11.
PMID: 29419641
Background: From a historical standpoint the epidemiology of exfoliation syndrome (XFS) is one of the most controversial subjects in ophthalmic literature. Current literature abounds with studies on the prevalence of...
10.
Hollo G, Katsanos A, Boboridis K, Irkec M, Konstas A
Drugs
. 2017 Dec;
78(1):39-64.
PMID: 29196953
Glaucoma therapy-related ocular surface disease (OSD) is a serious pathology with a broad spectrum of insidious clinical presentations and complex pathogenesis that undermines long-term glaucoma care. Preservatives, especially benzalkonium chloride...